Form 8-K - Current report:
SEC Accession No. 0001493152-24-009173
Filing Date
2024-03-07
Accepted
2024-03-07 10:28:08
Documents
14
Period of Report
2024-03-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 36046
  Complete submission text file 0001493152-24-009173.txt   206107

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT plsh-20240305.xsd EX-101.SCH 3024
3 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT plsh-20240305_lab.xml EX-101.LAB 34240
4 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT plsh-20240305_pre.xml EX-101.PRE 22365
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3434
Mailing Address 5910 SOUTH UNIVERSITY BLVD C18-193 GREENWOOD VILLAGE CO 80121
Business Address 5910 SOUTH UNIVERSITY BLVD C18-193 GREENWOOD VILLAGE CO 80121 561-455-4822
PANACEA LIFE SCIENCES HOLDINGS, INC. (Filer) CIK: 0001552189 (see all company filings)

EIN.: 271085858 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38190 | Film No.: 24728549
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)